Latest news
Is PTC Therapeutics (PTCT) Undervalued As Profit And Revenue Guidance Jumped? - simplywall.stsimplywall.st · Mon, 10 Aug 2026 23:59:22 GMTWhat Monte Rosa Therapeutics (GLUE)'s Swing From Profit To Deeper Losses Means For Shareholders - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:26:18 GMTPalvella Therapeutics (PVLA) Earnings And QTORIN Hopes Keep Undervaluation In Focus - simplywall.stsimplywall.st · Sat, 08 Aug 2026 12:26:25 GMTIs Palvella Therapeutics (PVLA) Fully Valued Ahead Of QTORIN Approval? - Yahoo Finance SingaporeYahoo Finance Singapore · Sat, 08 Aug 2026 11:10:58 GMTTG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings - simplywall.stsimplywall.st · Thu, 06 Aug 2026 08:14:06 GMTAddex Therapeutics (ADXN) Surges 12.45%: Key Levels to Watch After Sharp Rally - Defined Outcome ETF - dars.gov.etdars.gov.et · Tue, 04 Aug 2026 20:47:38 GMTSharp Therapeutics Announces Closing of Non-Brokered Private Placement - TMX NewsfileTMX Newsfile · Wed, 29 Jul 2026 12:45:00 GMTSharp Therapeutics closes C$ 1.37 million private placement at C$ 0.91/share - BitgetBitget · Wed, 29 Jul 2026 07:00:00 GMT